Physician Photo

John Herbert (John) Growdon, MD

Director, Memory and Movement Disorders Unit

  • Phone: 617-726-1728
Department of Neurology
Clinical Interests
Parkinson's disease
Alzheimer's disease
Boston: Massachusetts General Hospital
Medical Education
MD, University of Pennsylvania School of Medicine
Residency, Massachusetts General Hospital
Residency, University of Chicago Hospitals
Board Certifications
Neurology, American Board of Psychiatry and Neurology
Patient Gateway
Yes, learn more
Patient Age Group
Accepting New Patients
Accepting New Patients

BiographyJohn Growdon is Professor of Neurology at the Harvard Medical School and attending neurologist at the Massachusetts General Hospital.  He graduated from Northwestern University in 1960 with a BA in English Literature and obtained the MD degree from the University of Pennsylvania in 1965.  His post-graduate training was in Internal Medicine at the University of Chicago Hospitals (1965-69), in Neurology at the Massahcusetts General Hospital (1971-74) and in Neurochemistry at the Massachusetts Institute of Technology (1975-1977).  Since 1982, he has directed the Memory and Movement Disorders Units at the Massachsuetts General Hospital, which provide diagnostic services and continuing care for individuals with Parkinson disease and related movement disorders, and for individuals with cognitive impairments and dementia, including Alzheimer disease.  

ResearchDr. Growdon founded the Massachusetts Alzheimer's Disease Research Center ( funded by the National Institute on Aging and currently serves as the Director of the Memory Disorders Unit, which is the clinical arm of the Center.  He is also Director of the Movement Disorders Unit, which is the clinical unit for the MGH Udall Center of Excellence for Parkinson Disease Research ( funded by the National Institute for Neurologic Diseases and Stroke.  His research interests center on the clinical neurology and neuropharmacology of Alzheimer and Parkinson diseases, along with efforts to uncover biologic markers of these disease that could lead to improved diagnostic accuracy and treatment. 


1.  Gomperts SN, Rentz DM,  Moran E, Becker JA, Locascio JJ, Klunk WE, Mathias CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA.  Imaging amyloid deposition in Lewy body diseases.  Neurology 2008;71:903-910.

2.  Atri A, Shaughnessy LW, Locascio JJ, Growdon JH.  Long-term course and effectiveness of combination therapy in Alzheimer disease.  Alzheimer Dis Assoc Disord  2008;22:209-222.

Parkinson's Symposium at MIND- 2008

Momentum in our Pursuit of Cures - Research advances in Parkinson's, Lewy Body dementia, and Parkinson's-Plus disorders. Anne B. Young, MD, PhD, Director, MassGeneral Institute for Neurodegenerative Disease (MIND), formerly Chief of Neurology Service.

Neurology Bicentennial Celebration, 2011 Part I

Neurology Bicentennial Celebration, October 13, 2011. Past History of MGH Neurology; Overview of MGH Neurology; Telestroke and Acute Stroke Service; Neurodegenerative Disorders; Pediatric Neurology.

E Pluribus Unum for Parkinson Disease - Researchers Draw on Sources to Improve Treatment of PD

What do Gaucher’s disease, gout, and amyloid plaques have in common? For researchers at the MGH, each of them may shed light on the causes and treatment of Parkinson’s disease.

Neurology Associates
15 Parkman Street
Boston, MA 02114-3117

Phone: 617-726-1728
Fax: 617-726-4101